eFFECTOR Therapeutics (EFTR) Competitors $0.0004 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends EFTR vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ARAV, ACABW, ACABU, and BFRIWShould you be buying eFFECTOR Therapeutics stock or one of its competitors? The main competitors of eFFECTOR Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry. eFFECTOR Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera eFFECTOR Therapeutics (NASDAQ:EFTR) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, community ranking, earnings and dividends. Does the media favor EFTR or ATNFW? In the previous week, eFFECTOR Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score. Company Overall Sentiment eFFECTOR Therapeutics Neutral 180 Life Sciences Neutral Which has preferable earnings and valuation, EFTR or ATNFW? 180 Life Sciences has lower revenue, but higher earnings than eFFECTOR Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioeFFECTOR Therapeutics$3.55M0.00-$35.81M-$13.080.00180 Life SciencesN/AN/AN/AN/AN/A Do analysts recommend EFTR or ATNFW? eFFECTOR Therapeutics presently has a consensus target price of $24.00, suggesting a potential upside of 5,999,900.00%. Given eFFECTOR Therapeutics' higher probable upside, research analysts plainly believe eFFECTOR Therapeutics is more favorable than 180 Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eFFECTOR Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is EFTR or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets eFFECTOR TherapeuticsN/A N/A -146.23% 180 Life Sciences N/A N/A N/A Does the MarketBeat Community favor EFTR or ATNFW? eFFECTOR Therapeutics received 23 more outperform votes than 180 Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformeFFECTOR TherapeuticsOutperform Votes2379.31% Underperform Votes620.69% 180 Life SciencesN/AN/A Do institutionals and insiders hold more shares of EFTR or ATNFW? 57.7% of eFFECTOR Therapeutics shares are held by institutional investors. 4.7% of eFFECTOR Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryeFFECTOR Therapeutics beats 180 Life Sciences on 6 of the 7 factors compared between the two stocks. Ad TradingTips5 Stocks Under $5Ready to discover some hidden gems in the stock market? We’ve put together a report of 5 stocks under $5 with huge potential. Whether you’re looking for value or growth, these stocks have the potential to help you make your next winning investment.[Download Your Free Report Here] Get eFFECTOR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for EFTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFTR vs. The Competition Export to ExcelMetriceFFECTOR TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$6.96B$5.20B$8.49BDividend YieldN/A7.94%7.52%4.17%P/E Ratio0.006.6099.3713.61Price / Sales0.00384.031,664.5090.86Price / CashN/A46.3937.5333.51Price / Book0.005.654.745.10Net Income-$35.81M$152.32M$116.38M$224.54M7 Day PerformanceN/A-1.75%-0.82%-0.81%1 Month PerformanceN/A14.51%5.49%2.99%1 Year PerformanceN/A37.44%34.03%25.24% eFFECTOR Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFTReFFECTOR TherapeuticsN/A$0.00flat$24.00+5,999,900.0%-100.0%$2,000.00$3.55M0.0010ATNFW180 Life SciencesN/A$0.01flatN/A+9.0%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.05flatN/A+219.2%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03flatN/A-93.3%$0.00$65,122.000.0040Positive NewsGap DownALVOWAlvotechN/A$3.01-5.9%N/A+115.0%$0.00$306.77M0.004Gap DownALVOAlvotech2.5648 of 5 stars$12.92-0.8%$18.00+39.3%+45.5%$0.00$93.38M-4.881,026News CoverageARAVAravive0.8595 of 5 stars$0.04flatN/AN/A$0.00$9.14M-0.0420High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-37.3%$0.00N/A0.004Positive NewsACABUAtlantic Coastal Acquisition Corp. IIN/A$12.54flatN/A+19.1%$0.00N/A0.004BFRIWBiofronteraN/A$0.08+14.3%N/A+300.0%$0.00$35.24M0.0070Gap Up Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Alvotech Alternatives Aravive Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EFTR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
